NCT04834934View on ClinicalTrials.gov

Artificial Intelligence - SARS-CoV-2 (COVID-19) Risk Evaluation

CompletedOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

February 16, 2020

Primary Completion Date

September 30, 2020

Study Completion Date

June 30, 2021

Conditions
Covid19
Trial Locations (1)

20132

IRCCS San Raffaele, Milan

Sponsors
All Listed Sponsors
collaborator

Regione Lombardia

OTHER

collaborator

Orobix Srl

UNKNOWN

collaborator

Microsoft Corporation

INDUSTRY

collaborator

ASST Bergamo Est

UNKNOWN

collaborator

Centro Cardiologico Monzino

OTHER

collaborator

NVIDIA Corporation

UNKNOWN

collaborator

PORINI Srl

UNKNOWN

lead

IRCCS San Raffaele

OTHER

NCT04834934 - Artificial Intelligence - SARS-CoV-2 (COVID-19) Risk Evaluation | Biotech Hunter | Biotech Hunter